Bernstein Harold

President, R&D & CMOMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Mar 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Option exercise(M)30K$10.42$313K30K
Mar 10, 2026Sell(S)348$51.02$18K0
Mar 10, 2026Sell(S)30K$50.45$1.5M348

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2026Option exercise(M)30K$0267K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050172-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: